Abstract
Objective
To assess the evolution of retinal atrophy secondary to focal laser photocoagulation (FLP) for telangiectatic capillaries (TelCaps) in patients with diabetic macular oedema (DMO) or macular oedema secondary to retinal vein occlusion (MERVO).
Methods
A multicentre retrospective study was conducted in DMO or MERVO patients who underwent at least one FLP session for TelCaps followed for 36 months after FLP. The post-FLP horizontal diameter and surface area of atrophic scars were measured by Optical Coherence Tomography (OCT) and on the OCT infrared image, respectively. The degree of atrophy was quantified on the OCT B-scan.
Results
Sixty-nine eyes of 61 patients were included, corresponding to 86 laser scars analysed. The mean scar diameter increased from 315 ± 162 µm at month 1 (M1) to 350 ± 167 µm at M36 (mean increase: 35 µm, p < 0.001). The mean scar area increased from 0.10 ± 0.09 mm2 at M1 to 0.13 ± 0.10 mm2 at M36 (mean increase: 0.03 mm2, p < 0.01) At M1, 2 (2.6%), 74 (96%) and 1 (1.3%) scars were respectively considered “complete Outer Retinal Atrophy” (c-ORA), “incomplete Retinal pigment epithelium and Outer Retinal Atrophy” (i-RORA) and “complete Retinal pigment epithelium and Outer Retinal Atrophy” (c-RORA). At M36, 1 (1.8%), 40 (72.7%) and 14 (25.4%) scars were respectively considered c-ORA, i-RORA and c-RORA.
Conclusion
The size of retinal atrophy secondary to FLP for TelCaps increases significantly over time. Moreover, retinal atrophy undergoes phenotypic changes. Therefore, it seems imperative to respect a laser impact-free perifoveolar safety zone.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout



Similar content being viewed by others
Data availability
The datasets analysed during the current study are available from the corresponding author on reasonable request.
References
Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema. Diab Care. 2003;26:2653–64. https://doi.org/10.2337/diacare.26.9.2653.
Creuzot-Garcher C, Massin P, Srour M, Baudin F, Dot C, Nghiem-Buffet S, et al. Epidemiology of treated diabetes ocular complications in France 2008-2018-The LANDSCAPE French Nationwide Study. Pharmaceutics. 2022;14:2330. https://doi.org/10.3390/pharmaceutics14112330.
Klein R. The 15-year cumulative incidence of retinal vein occlusion: the beaver dam eye study. Arch Ophthalmol. 2008;126:513. https://doi.org/10.1001/archopht.126.4.513.
Darche M, Verschueren A, Castro Farias D, Borella Y, Paques M. Confocal microscopy of telangiectatic capillaries (TelCaps) and other features of microvascular remodeling following branch retinal vein occlusion. J Anat. 2023;243:235–44. https://doi.org/10.1111/joa.13743.
Chaperon M, Kodjikian L, Agard E, Mathis T, Billant J, El-Chehab H, et al. Screening of telangiectatic capillaries in chronic macular edema based on multimodal imaging: a study of 101 eyes. LyoMAC1 study. Graefes Arch Clin Exp Ophthalmol. Published online February 16, 2022. https://doi.org/10.1007/s00417-022-05592-y
Preliminary Report on Effects of Photocoagulation Therapy. Am J Ophthalmol. 1976;81:383-96. https://doi.org/10.1016/0002-9394(76)90292-0
Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98:766-85.
Thomley ME, Gross CN, Preda-Naumescu A, Chen KS, Swain T, Mason III JO, et al. Real-World Outcomes in Patients with Branch Retinal Vein Occlusion- (BRVO-) Related Macular Edema Treated with Anti-VEGF Injections Alone versus Anti-VEGF Injections Combined with Focal Laser. Figus M, ed. J Ophthalmol. 2021;2021:1-5. https://doi.org/10.1155/2021/6641008
Paques M, Philippakis E, Bonnet C, Falah S, Ayello-Scheer S, Zwillinger S, et al. Indocyanine-green-guided targeted laser photocoagulation of capillary macroaneurysms in macular oedema: a pilot study. Br J Ophthalmol. 2017;101:170–4. https://doi.org/10.1136/bjophthalmol-2015-308142.
Séjournet L, Kodjikian L, Elbany S, Allignet B, Agard E, Chaperon M, et al. Focal photocoagulation as an adjunctive therapy to reduce the burden of intravitreal injections in macula edema patients, the LyoMAC2 study. Pharmaceutics. 2023;15:308. https://doi.org/10.3390/pharmaceutics15020308.
Ogura S, Yasukawa T, Kato A, Kuwayama S, Hamada S, Hirano Y, et al. Indocyanine green angiography-guided focal laser photocoagulation for diabetic macular edema. Ophthalmologica. 2015;234:139–50. https://doi.org/10.1159/000437360.
Nozaki M, Kato A, Yasukawa T, Suzuki K, Yoshida M, Ogura Y. Indocyanine green angiography-guided focal navigated laser photocoagulation for diabetic macular edema. Jpn J Ophthalmol. 2019;63:243–54. https://doi.org/10.1007/s10384-019-00662-x.
Datlinger F, Datlinger A, Pollreisz A, Sacu S, Schmidt-Erfurth U, Datlinger P. Intraprocedural OCT monitoring of the immediate treatment response during indocyanine green angiography-guided laser therapy of teleangiectatic capillaries in diabetic macular edema. Sci Rep. 2022;12:2315. https://doi.org/10.1038/s41598-022-05950-0.
Maeshima K, Utsugi-Sutoh N, Otani T, Kishi S. Progressive enlargment of scattered photocoagulation scars in diabetic retinopathy. Retina. 2004;24:507–11. https://doi.org/10.1097/00006982-200408000-00002.
Shah SS. The evolution of argon laser photocoagulation scars in patients with the ocular histoplasmosis syndrome. Arch Ophthalmol. 1988;106:1533. https://doi.org/10.1001/archopht.1988.01060140701038.
Curcio CA, Sloan KR, Kalina RE, Hendrickson AE. Human photoreceptor topography. J Comp Neurol. 1990;292:497–523. https://doi.org/10.1002/cne.902920402.
Hanhart J, Weill Y, Rozenman Y. In vivo study of the long term structural changes induced by Macular Argon Laser. Curr Eye Res. 2018;43:511–6. https://doi.org/10.1080/02713683.2017.1419572.
Dot C, Parier V, Behar-Cohen F, Benezra D, Jonet L, Goldenberg B, et al. Influence of age on retinochoroidal healing processes after argon photocoagulation in C57bl/6j mice. Mol Vis. 2009;15:670–84.
Sadda SR, Guymer R, Holz FG, Schmitz-Valckenberg S, Curcio CA, Bird AC, et al. Consensus definition for atrophy associated with age-related macular degeneration on OCT. Ophthalmology. 2018;125:537–48. https://doi.org/10.1016/j.ophtha.2017.09.028.
Abdelfattah NS, Sadda J, Wang Z, Hu Z, Sadda S. Near-infrared reflectance imaging for quantification of atrophy associated with age-related macular degeneration. Am J Ophthalmol. 2020;212:169–74. https://doi.org/10.1016/j.ajo.2020.01.005.
Cole ED, Novais EA, Louzada RN, Moult EM, Lee BK, Witkin AJ, et al. Visualization of changes in the choriocapillaris, choroidal vessels, and retinal morphology after focal laser photocoagulation using OCT angiography. Investig Opthalmol Vis Sci. 2016;57:OCT356 https://doi.org/10.1167/iovs.15-18473.
Kozak I, Oster SF, Cortes MA, Dowell D, Hartmann K, Kim JS, et al. Clinical evaluation and treatment accuracy in diabetic macular edema using navigated laser photocoagulator NAVILAS. Ophthalmology. 2011;118:1119–24. https://doi.org/10.1016/j.ophtha.2010.10.007.
Kernt M, Cheuteu RE, Cserhati S, Seidensticker F, Liegl RG, Lang J, et al. Pain and accuracy of focal laser treatment for diabetic macular edema using a retinal navigated laser (Navilas®). Clin Ophthalmol. Published online February 2012;289. https://doi.org/10.2147/OPTH.S27859
Muqit MMK, Gray JCB, Marcellino GR, Henson DB, Young LB, Charles SJ, et al. Fundus autofluorescence and Fourier-domain optical coherence tomography imaging of 10 and 20 millisecond Pascal retinal photocoagulation treatment. Br J Ophthalmol. 2009;93:518–25. https://doi.org/10.1136/bjo.2008.148833.
Higaki M, Nozaki M, Yoshida M, Ogura Y. Less expansion of short-pulse laser scars in panretinal photocoagulation for diabetic retinopathy. J Ophthalmol. 2018;2018:1–8. https://doi.org/10.1155/2018/9371895.
Nagpal M, Marlecha S, Nagpal K. Comparison of laser photocoagulation for diabetic retinopathy using 532-nm standard laser versus multispot pattern scan laser. Retina. 2010;30:452–8. https://doi.org/10.1097/IAE.0b013e3181c70127.
Shiraya T, Kato S, Shigeeda T, Yamaguchi T, Kaiya T Comparison of burn size after retinal photocoagulation by conventional and high-power short-duration methods. Acta Ophthalmol (Copenhagen). 2014;92. https://doi.org/10.1111/aos.12393
Luttrull JK. Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema. Br J Ophthalmol. 2005;89:74–80. https://doi.org/10.1136/bjo.2004.051540.
Vujosevic S, Bottega E, Casciano M, Pilotto E, Convento E, Midena E. Microperimetry and fundus autofluorescence in diabetic macular edema: Subthreshold Micropulse Diode Laser Versus Modified Early Treatment Diabetic Retinopathy Study Laser Photocoagulation. Retina. 2010;30:908–16. https://doi.org/10.1097/IAE.0b013e3181c96986.
Midena E. Microperimetry. Arch Soc Espanola Oftalmol. 2006;81:183–6.
Virgili G, Bini A Laser photocoagulation for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2007;CD004763. https://doi.org/10.1002/14651858.CD004763.pub2
Author information
Authors and Affiliations
Contributions
Conception: DV, LS, CD. Design: DV, LS, CD. Supervision: DV, LS, CD. Materials: DV, LS, EA, IF, BM, CD, TM, CB, PD, LK Data collection and processing: DV, LS, BA Analysis and interpretation: BA, DV Literature review: DV, LS, CD Writer: DV, LS, CD Critical review: DV, LS, EA, IF, BM, BA, CD, CB, TM, PD, LK.
Corresponding author
Ethics declarations
Competing interests
CD is a consultant for Abbvie, Bayer, Horus Pharma, Novartis and Roche. L. Kodjikian is a consultant for Allergan/Abbvie, Bayer, Horus, Novartis, Roche and Théa. T. Mathis is a consultant for Allergan/Abbvie, Bayer, GSK, Horus and Novartis. All other authors have no conflicts of interest to declare.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Vingerder, D., Sejournet, L., Allignet, B. et al. Long-term evolution of retinal atrophy after focal laser photocoagulation of telangiectatic capillaries: LyoMAC3 study. Eye 40, 117–122 (2026). https://doi.org/10.1038/s41433-025-04111-7
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41433-025-04111-7


